Log in
SEARCH
All
News
CPD
CATEGORIES
Upcoming Events
Podcasts
On demand
Allergy
Asthma
COPD
Cystic fibrosis
End-of-life care
ILD
Infections
Infectious diseases
Interventional procedures
Lung cancer
Medicines
Medicopolitical
Podcast
Public health
Research
Sleep
About
About the limbic
Contact
Website Disclaimer
Privacy Policy
Terms & Conditions
news
cpd
Search
All
News
CPD
Account
Saved
SEARCH
All
News
CPD
CATEGORIES
Allergy
Asthma
COPD
Cystic fibrosis
End-of-life care
ILD
Infections
Infectious diseases
Interventional procedures
Lung cancer
Medicines
Medicopolitical
Podcast
Public health
Research
Sleep
Events
Podcasts
On demand
Log out
A third of asthma patients are using OCS at ‘toxic’ dosages
Asthma
New home and new leader for Woolcock
Research
Special report: leadership chaos strikes the RACP
Medical politics
Why the pathology bulk-billing campaign is more about driving industry profits than saving you money
Financial
Pharma funding: which specialties accept the most payments?
Financial
Allergic bronchopulmonary aspergillosis: new guidelines
Allergy
MORE NEWS
Is it time for routine EBUS-TBNA staging in NSCLC?
Lung cancer
Why medical indemnity is back on the agenda
Financial
Pulmonary embolism death attributed to hospital warfarin decision
Interventional procedures
Review finds key issues with asthma attack treatment trials
Asthma
Oral steroids offer short term benefit in infant wheeze
Healthcare private equity acquisitions on the rise in Australia
Financial
Institute launches cultural probe amid sexual harassment claims
sexism
Use of PROMs in ILD: not yet perfect but important
ILD
RACP boss resigns as college goes into the red
medical education
Patients relieved by Respiratory Rapid Access Service
Research
Therapy for NTM infections has to move beyond antibiotics
Infections
Urgent regulation needed on ‘risky’ medical AI
e-health
more news